Please ensure Javascript is enabled for purposes of website accessibility
Search
▲ S&P 500 +---% | ▲ Stock Advisor +---%
Accessibility Log In Help
Accessibility Menu
Arrow-Thin-Down
S&P 500
6,709.24
-0.0%
-$1.96
Arrow-Thin-Down
DJI
46,438.40
-0.0%
-$2.70
Arrow-Thin-Down
NASDAQ
22,821.80
+0.3%
+$66.65
Arrow-Thin-Down
Bitcoin
119,757.00
+2.0%
+2,308.62
Arrow-Thin-Down
AAPL
$257.41
+0.8%
+$1.96
Arrow-Thin-Down
AMZN
$222.53
+0.9%
+$1.90
Arrow-Thin-Down
GOOG
$244.32
-0.5%
-$1.22
Arrow-Thin-Down
META
$724.20
+1.0%
+$6.86
Arrow-Thin-Down
MSFT
$515.58
-0.8%
-$4.13
Arrow-Thin-Down
NVDA
$189.24
+1.1%
+$2.00
Arrow-Thin-Down
TSLA
$443.95
-3.4%
-$15.51
Daily Stock Gainers Daily Stock Losers Most Active Stocks
Home > Markets > Top Stock Losers

Biggest Stock Losers Today

View:

Top Stock Losers

Explore the biggest stock losers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock losers and decliners every day with market data, news, and analysis from our Foolish experts.

Related Articles

Featured Article
Bolt Revenue Jumps 39 Percent in Q2
Motley Fool Markets Team | Aug 14, 2025
Foolcom-Featured.png
Why Shares of Scilex Are Up Monday
James Halley | Oct 9, 2023
An analyst at H.C. Wainwright initiated coverage on the stock.
a scientist uses a pipette to work with medical samples.
Why Shares of Scilex Are Dropping Monday
James Halley | Sep 18, 2023
The company's shares are being dragged down by its soon-to-be-former parent company.
2valuestocks
Why Shares of Scilex Slumped This Week
James Halley | Apr 28, 2023
A stock sale and confusion regarding its parent company are factors dragging down the stock.
Patients in a waiting room
Why Bolt Biotherapeutics Stock Crashed Today
Keith Speights | Dec 6, 2021
The company announced disappointing interim data from a phase 1/2 study of its lead cancer program.
Scientists unhappy

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services